Doping Drug EPO Protects Brains of Premature Babies
By Sarah Thomas | August 28, 2014 10:35 AM EST
A study has found that an illegal hormone used by athletes to boost performance can help prevent brain injuries in premature babies.
A nurse cares for Nourhanne Ahmed, a premature baby girl, inside an incubator at a public hospital in the province of Sharkia, northeast of Cairo, June 10,2008. The Egyptian Health Ministry has complained over the lack of sufficient funds for public hospitals. REUTERS/Nasser Nuri (EGYPT)
Erythropoietin is a hormone that increases the red blood cells count in the body and is used to treat anaemia in some babies as anaemia is a condition in which the red blood cell count is lower than normal, the hormone when administered would increase the count.
A team at the University Hospital of Geneva found that premature infants had a reduced risk of brain injury when given three doses of the hormone erythropoietin (EPO) shortly after birth.
A team at the University Hospital of Geneva administered three doses of EPO to the premature babies and they found that it reduced risk of brain injury. They conducted a brain scan that showed the positive effects of this hormone on the infant's brain. It was also seen that EPO reduced the need for blood transfusion in premature babies.
EPO reduced the injury in the brain's white matter and grey matter. The injury rates were lowered from 36 per cent to 22 per cent in the brains white matter and it reduced from 19 per cent to 7 per cent in the grey matter.
Dr. Russia Ha-Vinh Leuchter, co-researcher of the study said that there were two groups of pre mature babies, one were given a placebo and the other were given the EPO. It was seen that the brain damage was much less among those who were treated with the erythropoietin hormone than those babies in the control group.
Leuchter stated that this was the first time they had found out the benefit of the hormone and its effects on a premature baby's brain. But the researchers are calling for a further study and clinical trials of EPO. Dr. Jane Hawdon, a consultant neonatologist at Barts Health NHS Trust said, "Any treatment that may reduce long term problems in pre-term babies warranted further review". Dr. Jane was not involved in the study.
Further research is required to find out if the hormone would work in the "critical weeks" after the birth of the premature babies.
She said, "We should note that the authors are not recommending immediate inclusion of this treatment into routine practice." She also threw a light on the fact that not many pre-term babies survive brain injury.
The study is published in the Journal of the American Medical Association.
To contact the editor, e-mail:
Most Popular Slideshows
- NFL MNF: Pittsburgh Steelers 30, Houston Texans 23 [PHOTOS]
- 2014 MLB World Series Game 1: San Francisco Giants 7, Kansas City Royals 1 [PHOTOS]
- 2014 MLB World Series - Game 2: Kansas City Royals 7, San Francisco Giants 2 [PHOTOS]
- NFL Thursday Recap - Denver Broncos 35, San Diego Chargers 21: Peyton Manning Has 3 TDs In Easy Win [PHOTOS]
Join the Conversation
- 12 Terrifyingly Healthy Halloween Treats
- New York Doctor Tests Positive For Ebola
- Kate Middleton Back To Herself After Struggling With Hyperemesis Gravidarum
- Ebola Vaccine: Johnson & Johnson Confident Of Human Trials In January And Market Delivery in May Next Year
- ‘Death Sentence’ For 50,000 Australians With The Refusal Of Costly Hep C Treatment
- Xiaomi Redmi 1S vs. Sharp Aquos Crystal – Specifications, Features And Price Showdown
- ASUS Releases A Teaser Indicating The Arrival of New Zenfone and ZenWatch On October 28
- Boy Stoned To Death For Alleged Rape, Victim Receives Dowry From Militants
- Three Dual SIM Samsung Galaxy Note 4 Duos Variants Comes To China
- Russia is Creating Underwater Combat Robots to Protect its Arctic Territories
- ‘Lone Wolf’ Attack on Canada Parliament Hill Could be ISIS-Related
- Android Lollipop 5.0 Confirmed for Nov 3 Rollout as Nexus 6 Global Release Date is Delayed – Reports